§ Funding Round
Series C funding round for Edgewise Therapeutics raising $95M in December 2020
Series C funding round for Edgewise Therapeutics raising $95M in December 2020
| Investor | Firm Type | Partner |
|---|---|---|
| Organization | — | |
| Angel | carol gallagher | |
| Angel | robert garland | |
Nextech Invest | — | — |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
Janus Henderson Investors | — | — |
Logos Capital | — | — |
New Leaf Ventures | — | — |
| Organization | — | |
| Organization | — | |
Surveyor Capital | — | — |
Viking Global InvestorsLEAD | — | — |
| Organization | — |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$145M
Top Valuation
-
Edgewise Therapeutics raised $95M in a Series C round.
The round was announced on 12/01/20.
The round was led by Viking Global Investors.
